Publicacions en col·laboració amb investigadors/es de Hospital Universitario de Salamanca (4)

2024

  1. Targeting NOX2 and glycolytic metabolism as a therapeutic strategy in acute myeloid leukaemia

    Biomarker Research

2022

  1. A 29-gene signature associated with NOX2 discriminates acute myeloid leukemia prognosis and survival

    American Journal of Hematology, Vol. 97, Núm. 4, pp. 448-457

  2. Reactive Oxygen Species and Metabolism in Leukemia: A Dangerous Liaison

    Frontiers in immunology, Vol. 13, pp. 889875

2019

  1. SHP1 and SHP2 inhibition enhances the pro-differentiative effect of phorbol esters: An alternative approach against acute myeloid leukemia

    Journal of Experimental and Clinical Cancer Research, Vol. 38, Núm. 1